Back to search
FDAFDA · Food and drugs·Recall number D-0126-2017

Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network

Published November 16, 2016 · Recall initiated: September 19, 2016

Summary

FDA records drug Class II recall D-0126-2017, published November 16, 2016 and initiated September 19, 2016. Recalling firm: Wells Pharmacy Network, LLC; Status: Terminated; Reported quantity: 690 pellets; Lot: BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent and Subpotent drugs

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wells Pharmacy Network, LLC
Distributor
U.S.
Lot
BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network recalled?

Yes. FDA published recall D-0126-2017 on November 16, 2016. Reported hazard: Superpotent and Subpotent drugs

What should I do if I have this product?

Voluntary: Firm initiated · Telephone